Forward Pharma A/S (Forward Pharma A/S) Interest Expense : $-0.10 Mil (TTM As of Jun. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Forward Pharma A/S's interest expense for the six months ended in Jun. 2022 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.10 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Forward Pharma A/S's Operating Income for the six months ended in Jun. 2022 was $ -1.82 Mil. Forward Pharma A/S's Interest Expense for the six months ended in Jun. 2022 was $ -0.01 Mil. Forward Pharma A/S did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Forward Pharma A/S Interest Expense Historical Data

The historical data trend for Forward Pharma A/S's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forward Pharma A/S Interest Expense Chart

Forward Pharma A/S Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Interest Expense

Get a 7-Day Free Trial

-2.90

-0.09

-0.19

Forward Pharma A/S Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Interest Expense	Get a 7-Day Free Trial															-	-0.10	-0.10	-0.09	-0.01

Forward Pharma A/S Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.10 Mil.

Forward Pharma A/S (OTCPK:FWPAY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Forward Pharma A/S's Interest Expense for the six months ended in Jun. 2022 was $-0.01 Mil. Its Operating Income for the six months ended in Jun. 2022 was $-1.82 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2022 was $0.00 Mil.

Forward Pharma A/S's Interest Coverage for the quarter that ended in Jun. 2022 is calculated as

Forward Pharma A/S did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Forward Pharma A/S (Forward Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100

Website

https://www.forward-pharma.com

Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.